1. Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-Study 
Maja Mockenhaupt, Cecile Viboud, Ariane Dunant, Luigi Naldi, Sima Halevy, Jan Nico Bouwes Bavinck, Alexis Sidoroff, Jürgen Schneck, Jean-Claude Roujeau, Antoine Flahault 
Journal of Investigative Dermatology 
Volume 128, Issue 1, Pages (January 2008)
DOI: /sj.jid
Copyright © 2008 The Society for Investigative Dermatology, Inc Terms and Conditions

2. Figure 1
Distribution of the number of days between beginning of drug use (drug initiation) and onset of the adverse reaction for selected drugs. (a and b) Highly associated drugs, (c and d) non-associated drugs, and (e and f) drugs with doubtful association. Dashed lines indicate cases with co-medication with another “highly suspected” drug initiated within less than 8 weeks before the onset of the reaction.
Journal of Investigative Dermatology  , 35-44DOI: ( /sj.jid )
Copyright © 2008 The Society for Investigative Dermatology, Inc Terms and Conditions